Drugs / Calanolide A
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00005120 | Apr 2000 → ? | HIV infectious disease | Sarawak MediChem Pharmaceuticals | Unknown | No outcome recorded |
| Phase 1 | NCT00002243 | — | HIV infectious disease | Sarawak MediChem Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | (+)-Calanolide A | “A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never...” NCT00002243 ↗ |
| Action | Inhibit | “A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never...” NCT00002243 ↗ |